- In This Issue on 02-September-2024
-
Yoo JH
- KMID: 2559202
- J Korean Med Sci.
- 2024 Sep;39(34):e269.
- doi: 10.3346/jkms.2024.39.e269
-
- CITED
-
- Close
- SHARE
-
- Close
- Impacts of Tocolytics on Maternal and Neonatal Glucose Levels in Women With Gestational Diabetes Mellitus
-
Hong S, Seol HJ, Lee J, Hwang HS, Sung JH, Kwon JY, Lee SM, Seong WJ, Choi SR, Kim SC, Kim HS, Lee SJ, Choi SK, Lee KA, Ko HS, Park HS, on behalf of Gestational Diabetes Study Group
- KMID: 2559198
- J Korean Med Sci.
- 2024 Sep;39(34):e236.
- doi: 10.3346/jkms.2024.39.e236
Background: We investigated the impacts of tocolytic agents on maternal and neonatal blood glucose levels in women with gestational diabetes mellitus (GDM) who used tocolytics for preterm labor. Methods: This multi-center,... -
- CITED
-
- Close
- SHARE
-
- Close
- Lack of Parental Control Is Longitudinally Associated With Higher Smartphone Addiction Tendency in Young Children: A Population-Based Cohort Study
-
Lee J, Lee S, Shin Y
- KMID: 2559200
- J Korean Med Sci.
- 2024 Sep;39(34):e254.
- doi: 10.3346/jkms.2024.39.e254
The purpose of the current study was to examine the risk factors of young children’s smartphone addiction in a longitudinal study design. Data collected from 313 participants (mean age, 4.5... -
- CITED
-
- Close
- SHARE
-
- Close
- Bevacizumab Alone Versus Bevacizumab Plus Irinotecan in Patients With Recurrent Glioblastoma: A Nationwide Population-Based Study
-
Lee Y, Lee E, Roh TH, Kim SH
- KMID: 2559199
- J Korean Med Sci.
- 2024 Sep;39(34):e244.
- doi: 10.3346/jkms.2024.39.e244
Background: For treating recurrent glioblastoma, for which there is no established treatment, the antiangiogenic antibody, bevacizumab, is used alone or with irinotecan. This study was aimed at comparing the survival... -
- CITED
-
- Close
- SHARE
-
- Close
- High-Dose Corticosteroid Use in Severe to Critically Ill Patients With COVID-19: A Nationwide PopulationBased Matched Cohort Study
-
Lee R, Cho SY, Lee DG, Nho D
- KMID: 2559201
- J Korean Med Sci.
- 2024 Sep;39(34):e255.
- doi: 10.3346/jkms.2024.39.e255
Background: Systemic corticosteroids have become the standard of care for severe to critically ill patients with coronavirus disease 2019 (COVID-19). However, the real-world efficacy and safety outcomes associated with a... -
- CITED
-
- Close
- SHARE
-
- Close
- Contemporary Statistics of Acute Ischemic Stroke and Transient Ischemic Attack in 2021: Insights From the CRCS-K-NIH Registry
-
Kim DY, Park TH, Cho YJ, Park JM, Lee K, Lee M, Lee J, Bae SY, Hong DY, Jung H, Ko E, Guk HS, Kim BJ, Kim JY, Kang J, Han MK, Park SS, Hong KS, Park HK, Lee JY, Lee BC, Yu KH, Oh MS, Kim DE, Gwak DS, Lee SJ, Kim JG, Lee J, Kwon DH, Cha JK, Kim DH, Kim JT, Choi KH, Kim H, Choi JC, Kim JG, Kang CH, Sohn Si, Hong JH, Park H, Lee SH, Kim C, Shin DI, Yum KS, Kang K, Park KY, Jeong HB, Park CY, Lee KJ, Kwon JH, Kim WJ, Lee JS, Bae HJ, on behalf of the CRCS-K Investigators
- KMID: 2559203
- J Korean Med Sci.
- 2024 Sep;39(34):e278.
- doi: 10.3346/jkms.2024.39.e278
This report presents the latest statistics on the stroke population in South Korea, sourced from the Clinical Research Collaborations for Stroke in Korea-National Institute for Health (CRCS-K-NIH), a comprehensive, nationwide,... -
- CITED
-
- Close
- SHARE
-
- Close
